BioNTech stock after-hours at EUR 87.80: plus 1.97 percent versus Lang & Schwarz prior close
Published on 10/05/2026 at 19:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
BioNTech stock traded at EUR 87.80 in after-hours trading at 7:57 p.m. CEST on October 5, 2026, up 1.97 percent versus the Lang & Schwarz prior close of EUR 86.10.
Trading day
The price indication was higher than the previous Lang & Schwarz close as the after-hours session continued. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of BioNTech stock.
Updated lung cancer data
In a September 14, 2026 press release, BioNTech and OncoC4 reported updated data from stage 1 of the PRESERVE-003 Phase 3 trial. Median overall survival was 18.5 months for patients treated with investigational gotistobart, compared with 10.0 months for patients treated with docetaxel. The data cut-off was July 17, 2026, and the company said the pivotal stage 2 portion of the trial was ongoing at more than 160 sites globally.
